Monday, September 21, 2020
MARKET UPDATE
Advertisement

TheCable

Advertisement
 ON THE GO

NAFDAC reopens pharmaceutical companies shut over sale of codeine syrup

NAFDAC reopens pharmaceutical companies shut over sale of codeine syrup
May 12
18:00 2018

The National Agency for Food and Drug Administration and Control (NAFDAC) has lifted the shutdown order on three pharmaceutical companies that were implicated in the illegal manufacture and distribution of codeine-containing syrup.

Advertisement

The three companies, Peace Standard Pharmaceutical Limited, Adewole Industrial Estate, Lubcon Avenue, Ilorin, Kwara State; Bioraj Pharmaceutical Limited, Kaima Road, Ilorin and Emzor Pharmaceuticals Industrial Limited, Ajao Estate, Lagos, were closed on May 7.

Mojisola Adeyeye, director general of NAFDAC, had said the companies were shut for apparent resistance to provide needed documents during the organisation’s inspection in Ilorin and Lagos on May 2.

However, in a statement on Saturday, Adeyeye said the directive to lift the shut down is following meetings held with the companies and its directorates of investigation and enforcement (I&E), drug evaluation research (DER) and narcotics and controlled substances (NCS).

Advertisement

According to NAFDAC, the production of codeine syrup is to be stopped immediately until further notice while investigations continue.

“Therefore, the hold placed on the active pharmaceutical ingredient and the already made codeine syrups stands. NAFDAC will monitor the compliance,” Adeyeye said.

“All codeine products are to be recalled and the process verified through audit trail verified by NAFDAC

Advertisement

“Embargo has been placed on new applications for permit or renewals for the importation of codeine as an active pharmaceutical ingredient for cough preparations, i.e., NAFDAC will not issue any permit until further notice

“The companies have been charged with administrative fees that are commensurate with the respective violations.”

NAFDAC said it would hold a stakeholders meeting on the codeine crisis in a few days to develop a roadmap for the supply chain distribution and the future of codeine syrup manufacturing.

The federal government in April announced a ban on the production and import of cough syrup containing codeine.

Advertisement

0 Comments

No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment